CVS Health Corporation
CVS
$64.10
$0.4350.68%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 93.55% | 162.93% | -64.22% | -49.10% | -45.50% |
| Total Depreciation and Amortization | 3.36% | -0.49% | -4.16% | -5.84% | -6.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.93% | -53.63% | -18.83% | -37.87% | -56.52% |
| Change in Net Operating Assets | -99.78% | -97.26% | 192.57% | 132.06% | 72.70% |
| Cash from Operations | -17.01% | -36.25% | 10.71% | 5.89% | -11.43% |
| Capital Expenditure | -11.15% | -6.53% | -6.72% | 2.99% | -8.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -11,851.08% | -11,519.72% | -10,015.34% | -10,372.46% | 4.79% |
| Divestitures | -- | 135.22% | 135.72% | -- | -- |
| Other Investing Activities | -33.69% | 31.59% | 29.09% | 83.19% | 64.08% |
| Cash from Investing | -313.89% | -210.40% | -208.89% | -114.74% | 4.07% |
| Total Debt Issued | -- | -- | 1,612.06% | 709.66% | -- |
| Total Debt Repaid | -93.92% | -16.96% | -48.88% | 36.85% | 58.93% |
| Issuance of Common Stock | -49.73% | -54.28% | -43.03% | -44.79% | 0.36% |
| Repurchase of Common Stock | 43.33% | -58.75% | -59.32% | -73.33% | -2,203.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.74% | -7.87% | -8.56% | -10.14% | -10.74% |
| Other Financing Activities | -154.43% | -286.36% | -103.33% | -9.43% | -150.97% |
| Cash from Financing | 125.51% | 113.06% | 109.51% | 52.50% | 7.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -878.50% | -192.59% | -23.21% | 22.58% | -62.74% |
